(RMS) Hermes International SCA - Ratings and Ratios
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0000052292
Leather goods, Ready-to-wear, Accessories, Silk, Perfumes
Dividends
| Dividend Yield | 1.22% |
| Yield on Cost 5y | 3.20% |
| Yield CAGR 5y | 53.10% |
| Payout Consistency | 93.4% |
| Payout Ratio | 37.5% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 25.9% |
| Value at Risk 5%th | 40.0% |
| Relative Tail Risk | -5.99% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.24 |
| Alpha | -12.85 |
| CAGR/Max DD | 0.44 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.462 |
| Beta | 0.316 |
| Beta Downside | 0.264 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.14% |
| Mean DD | 9.83% |
| Median DD | 8.55% |
Description: RMS Hermes International SCA December 01, 2025
Hermès International SCA (ticker RMS) is a French luxury group that designs, manufactures, and sells a broad portfolio of high-end products-including leather goods, ready-to-wear, accessories, silk, perfume, watches, and tableware-through its own boutiques worldwide and a limited set of specialty distributors.
In FY 2023 the company generated €12.2 billion in revenue, with an operating margin of roughly 30 %, reflecting the premium pricing power typical of the ultra-luxury segment. Growth was led by Asia-Pacific (especially China and Japan), where sales rose ~12 % year-over-year, while the U.S. market delivered modest double-digit growth despite a softer macro environment.
Key economic drivers for Hermès include the resilience of discretionary spending among high-net-worth consumers, the relative weakness of the euro against the dollar (which boosts reported earnings), and the limited exposure to mass-market e-commerce that preserves brand exclusivity. Conversely, the firm remains vulnerable to geopolitical tensions that could disrupt its Asian supply chain or dampen affluent travel-related demand.
For a data-driven deep-dive into Hermès’ valuation metrics and scenario analysis, you may find ValueRay’s research platform a useful next step.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (6.85b TTM) > 0 and > 6% of Revenue (6% = 1.39b TTM) |
| FCFTA 0.41 (>2.0%) and ΔFCFTA 23.53pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 48.18% (prev 80.62%; Δ -32.44pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.45 (>3.0%) and CFO 9.83b > Net Income 6.85b (YES >=105%, WARN >=100%) |
| Net Debt (-8.26b) to EBITDA (10.82b) ratio: -0.76 <= 3.0 (WARN <= 3.5) |
| Current Ratio 4.50 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (105.0m) change vs 12m ago 0.02% (target <= -2.0% for YES) |
| Gross Margin 68.88% (prev 69.99%; Δ -1.11pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 109.8% (prev 65.67%; Δ 44.11pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 112.8 (EBITDA TTM 10.82b / Interest Expense TTM 85.0m) >= 6 (WARN >= 3) |
Altman Z'' 10.21
| (A) 0.51 = (Total Current Assets 14.37b - Total Current Liabilities 3.19b) / Total Assets 21.83b |
| (B) 0.10 = Retained Earnings (Balance) 2.25b / Total Assets 21.83b |
| (C) 0.45 = EBIT TTM 9.59b / Avg Total Assets 21.14b |
| (D) 3.31 = Book Value of Equity 17.23b / Total Liabilities 5.21b |
| Total Rating: 10.21 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 88.61
| 1. Piotroski 6.50pt |
| 2. FCF Yield 4.14% |
| 3. FCF Margin 38.63% |
| 4. Debt/Equity 0.12 |
| 5. Debt/Ebitda -0.76 |
| 6. ROIC - WACC (= 30.86)% |
| 7. RoE 42.68% |
| 8. Rev. Trend 98.31% |
| 9. EPS Trend 3.56% |
What is the price of RMS shares?
As of December 11, 2025, the stock is trading at EUR 2129.00 with a total of 61,547 shares traded.
Over the past week, the price has changed by +1.19%, over one month by +2.06%, over three months by +1.72% and over the past year by -3.70%.
Over the past week, the price has changed by +1.19%, over one month by +2.06%, over three months by +1.72% and over the past year by -3.70%.
Is RMS a buy, sell or hold?
Hermes International SCA has no consensus analysts rating.
What are the forecasts/targets for the RMS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2391.7 | 12.3% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 2353.4 | 10.5% |
RMS Fundamental Data Overview November 27, 2025
Market Cap USD = 259.43b (222.88b EUR * 1.164 EUR.USD)
Market Cap EUR = 222.88b (222.88b EUR * 1.0 EUR.EUR)
P/E Trailing = 49.8827
P/E Forward = 42.1941
P/S = 14.1963
P/B = 13.324
P/EG = 5.6323
Beta = 1.034
Revenue TTM = 23.20b EUR
EBIT TTM = 9.59b EUR
EBITDA TTM = 10.82b EUR
Long Term Debt = 30.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 336.0m EUR (from shortTermDebt, last quarter)
Debt = 2.06b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -8.26b EUR (from netDebt column, last quarter)
Enterprise Value = 216.56b EUR (222.88b + Debt 2.06b - CCE 8.39b)
Interest Coverage Ratio = 112.8 (Ebit TTM 9.59b / Interest Expense TTM 85.0m)
FCF Yield = 4.14% (FCF TTM 8.96b / Enterprise Value 216.56b)
FCF Margin = 38.63% (FCF TTM 8.96b / Revenue TTM 23.20b)
Net Margin = 29.52% (Net Income TTM 6.85b / Revenue TTM 23.20b)
Gross Margin = 68.88% ((Revenue TTM 23.20b - Cost of Revenue TTM 7.22b) / Revenue TTM)
Gross Margin QoQ = 66.27% (prev none%)
Tobins Q-Ratio = 9.92 (Enterprise Value 216.56b / Total Assets 21.83b)
Interest Expense / Debt = 1.26% (Interest Expense 26.0m / Debt 2.06b)
Taxrate = 35.13% (1.23b / 3.50b)
NOPAT = 6.22b (EBIT 9.59b * (1 - 35.13%))
Current Ratio = 4.50 (Total Current Assets 14.37b / Total Current Liabilities 3.19b)
Debt / Equity = 0.12 (Debt 2.06b / totalStockholderEquity, last quarter 16.60b)
Debt / EBITDA = -0.76 (Net Debt -8.26b / EBITDA 10.82b)
Debt / FCF = -0.92 (Net Debt -8.26b / FCF TTM 8.96b)
Total Stockholder Equity = 16.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 31.38% (Net Income 6.85b / Total Assets 21.83b)
RoE = 42.68% (Net Income TTM 6.85b / Total Stockholder Equity 16.05b)
RoCE = 59.64% (EBIT 9.59b / Capital Employed (Equity 16.05b + L.T.Debt 30.0m))
RoIC = 37.98% (NOPAT 6.22b / Invested Capital 16.37b)
WACC = 7.12% (E(222.88b)/V(224.94b) * Re(7.18%) + D(2.06b)/V(224.94b) * Rd(1.26%) * (1-Tc(0.35)))
Discount Rate = 7.18% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 33.33 | Cagr: 0.01%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈6.81b ; Y1≈8.40b ; Y5≈14.34b
Fair Price DCF = 2326 (DCF Value 243.89b / Shares Outstanding 104.8m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 3.56 | EPS CAGR: -52.63% | SUE: 0.0 | # QB: 0
Revenue Correlation: 98.31 | Revenue CAGR: 37.73% | SUE: 0.87 | # QB: 1
EPS next Year (2026-12-31): EPS=48.64 | Chg30d=-0.442 | Revisions Net=-10 | Growth EPS=+14.5% | Growth Revenue=+8.8%
Market Cap EUR = 222.88b (222.88b EUR * 1.0 EUR.EUR)
P/E Trailing = 49.8827
P/E Forward = 42.1941
P/S = 14.1963
P/B = 13.324
P/EG = 5.6323
Beta = 1.034
Revenue TTM = 23.20b EUR
EBIT TTM = 9.59b EUR
EBITDA TTM = 10.82b EUR
Long Term Debt = 30.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 336.0m EUR (from shortTermDebt, last quarter)
Debt = 2.06b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -8.26b EUR (from netDebt column, last quarter)
Enterprise Value = 216.56b EUR (222.88b + Debt 2.06b - CCE 8.39b)
Interest Coverage Ratio = 112.8 (Ebit TTM 9.59b / Interest Expense TTM 85.0m)
FCF Yield = 4.14% (FCF TTM 8.96b / Enterprise Value 216.56b)
FCF Margin = 38.63% (FCF TTM 8.96b / Revenue TTM 23.20b)
Net Margin = 29.52% (Net Income TTM 6.85b / Revenue TTM 23.20b)
Gross Margin = 68.88% ((Revenue TTM 23.20b - Cost of Revenue TTM 7.22b) / Revenue TTM)
Gross Margin QoQ = 66.27% (prev none%)
Tobins Q-Ratio = 9.92 (Enterprise Value 216.56b / Total Assets 21.83b)
Interest Expense / Debt = 1.26% (Interest Expense 26.0m / Debt 2.06b)
Taxrate = 35.13% (1.23b / 3.50b)
NOPAT = 6.22b (EBIT 9.59b * (1 - 35.13%))
Current Ratio = 4.50 (Total Current Assets 14.37b / Total Current Liabilities 3.19b)
Debt / Equity = 0.12 (Debt 2.06b / totalStockholderEquity, last quarter 16.60b)
Debt / EBITDA = -0.76 (Net Debt -8.26b / EBITDA 10.82b)
Debt / FCF = -0.92 (Net Debt -8.26b / FCF TTM 8.96b)
Total Stockholder Equity = 16.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 31.38% (Net Income 6.85b / Total Assets 21.83b)
RoE = 42.68% (Net Income TTM 6.85b / Total Stockholder Equity 16.05b)
RoCE = 59.64% (EBIT 9.59b / Capital Employed (Equity 16.05b + L.T.Debt 30.0m))
RoIC = 37.98% (NOPAT 6.22b / Invested Capital 16.37b)
WACC = 7.12% (E(222.88b)/V(224.94b) * Re(7.18%) + D(2.06b)/V(224.94b) * Rd(1.26%) * (1-Tc(0.35)))
Discount Rate = 7.18% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 33.33 | Cagr: 0.01%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈6.81b ; Y1≈8.40b ; Y5≈14.34b
Fair Price DCF = 2326 (DCF Value 243.89b / Shares Outstanding 104.8m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 3.56 | EPS CAGR: -52.63% | SUE: 0.0 | # QB: 0
Revenue Correlation: 98.31 | Revenue CAGR: 37.73% | SUE: 0.87 | # QB: 1
EPS next Year (2026-12-31): EPS=48.64 | Chg30d=-0.442 | Revisions Net=-10 | Growth EPS=+14.5% | Growth Revenue=+8.8%